Search Results - "Fuldeore, Mahesh"

Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women by Fuldeore, Mahesh J, Soliman, Ahmed M

“…To estimate the prevalence of diagnosed endometriosis (DE) in women in the United States and assess the associated symptomatic burden. An online,…”
Get more information

The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study by Soliman, Ahmed M., Coyne, Karin S., Zaiser, Erica, Castelli-Haley, Jane, Fuldeore, Mahesh J.

“…Introduction: To examine the symptomatic burden of endometriosis on health-related quality of life (HRQL) in women in the United States (US). Methods: A cross…”
Get full text

Medication Compliance and Persistence: Terminology and Definitions by Cramer, Joyce A., BS, Roy, Anuja, MBA, MSc, Burrell, Anita, MBA, Fairchild, Carol J., PhD, Fuldeore, Mahesh J., PhD, RPh, MBA, Ollendorf, Daniel A., MPH, Wong, Peter K., PhD, RPh, MS, MBA

“…Abstract Objectives The aim of the study is to provide guidance regarding the meaning and use of the terms “compliance” and “persistence” as they relate to the…”
Get full text

Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs by Strand, Vibeke, Schiff, Michael, Tundia, Namita, Friedman, Alan, Meerwein, Sebastian, Pangan, Aileen, Ganguli, Arijit, Fuldeore, Mahesh, Song, Yan, Pope, Janet

“…Patient-reported outcomes (PROs) are important when evaluating treatment benefits in rheumatoid arthritis (RA). We compared upadacitinib, an oral, selective…”
Get full text

Patient-reported prevalence and symptomatic burden of uterine fibroids among women in the United States: findings from a cross-sectional survey analysis by Fuldeore, Mahesh J, Soliman, Ahmed M

“…To estimate the prevalence of women diagnosed with uterine fibroids and the associated symptom burden in the US. Responses of women aged 18-54 years, who…”
Get full text

Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT by Strand, Vibeke, Pope, Janet, Tundia, Namita, Friedman, Alan, Camp, Heidi S, Pangan, Aileen, Ganguli, Arijit, Fuldeore, Mahesh, Goldschmidt, Debbie, Schiff, Michael

“…To evaluate the effect of upadacitinib on patient-reported outcomes (PROs) in patients with RA who had an inadequate response to csDMARDs. Patients in…”
Get full text

Healthcare utilization and costs in women diagnosed with endometriosis before and after diagnosis: a longitudinal analysis of claims databases by Fuldeore, Mahesh, Ph.D, Yang, Hongbo, Ph.D, Du, Ella Xiaoyan, M.E.Sc, Soliman, Ahmed M., Ph.D, Wu, Eric Q., Ph.D, Winkel, Craig, M.D

“…Objective To assess healthcare resource utilization and costs during the 5 years before and 5 years after diagnosis among women with endometriosis, in…”
Get full text

Impact of uterine fibroid symptoms on health-related quality of life of US women: evidence from a cross-sectional survey by Soliman, Ahmed M., Margolis, Mary Kay, Castelli-Haley, Jane, Fuldeore, Mahesh J., Owens, Charlotte D., Coyne, Karin S.

“…Background: Uterine fibroids (UF) are associated with significant health-related quality of life (HRQL) impact. This study examined the impact of UF symptoms…”
Get full text

Temporal trends and predictors of salvage cancer treatment after failure following radical prostatectomy or radiation therapy: An analysis from the CaPSURE registry by Cary, K. Clint, Paciorek, Alan, Fuldeore, Mahesh J., Carroll, Peter R., Cooperberg, Matthew R.

“…BACKGROUND Prostate cancer treatment after failure of primary therapy by either radical prostatectomy or radiation therapy can vary greatly. This study sought…”
Get full text

Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT by Strand, Vibeke, Pope, Janet, Tundia, Namita, Friedman, Alan, Camp, Heidi S, Pangan, Aileen, Ganguli, Arijit, Fuldeore, Mahesh, Goldschmidt, Debbie, Schiff, Michael

“…An amendment to this paper has been published and can be accessed via the original article…”
Get full text

Chronic kidney disease in gout in a managed care setting by Fuldeore, Mahesh J, Riedel, Aylin A, Zarotsky, Victoria, Pandya, Bhavik J, Dabbous, Omar, Krishnan, Eswar

“…To study the prevalence of chronic kidney disease (CKD) and its impact on allopurinol dosing and uric acid control among patients with gout. This was a…”
Get full text

The Effect of Serum Urate on Gout Flares and Their Associated Costs: An Administrative Claims Analysis by Halpern, Rachel, Fuldeore, Mahesh J, Mody, Reema R, Patel, Pankaj A, Mikuls, Ted R

“…BACKGROUND:Increased serum urate (sUA) levels (≥6.0 mg/dL) are associated with increased likelihood of acute gout attacks, or “flares.” OBJECTIVES:Identify…”
Get full text

Patient Demographics, Quality of Life, and Disease Features of Men With Newly Diagnosed Prostate Cancer: Trends in the PSA Era by Glass, Allison S, Cowan, Janet E, Fuldeore, Mahesh J, Cooperberg, Matthew R, Carroll, Peter R, Kenfield, Stacey A, Greene, Kirsten L

“…Objective To describe how demographic and diagnostic characteristics of men with prostate cancer in the United States have changed since 1999, using data from…”
Get full text

Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis by Halpern, Rachel, Mody, Reema R., Fuldeore, Mahesh J., Patel, Pankaj A., Mikuls, Ted R.

“…ABSTRACT Objective: To determine the association between allopurinol compliance and serum urate (sUA) level; and examine the association between sUA and…”
Get full text

Add-back therapy use and its impact on LA persistence in patients with endometriosis by Fuldeore, Mahesh J., Marx, Steven E., Chwalisz, Kristof, Smeeding, James E., Brook, Richard A.

“…Abstract Objectives: Persistence and compliance in women with endometriosis who are receiving gonadotropin-releasing hormone agonists (GnRH-a) may be limited…”
Get full text

Factors Associated with Time to Endometriosis Diagnosis in the United States by Soliman, Ahmed M, Fuldeore, Mahesh, Snabes, Michael C

“…We aimed to quantify the time to diagnosis among women with endometriosis in the United States (US) and to identify patient- and physician-related factors…”
Get more information

Economic Burden of Patients with Inadequate Response to Targeted Immunomodulators for Rheumatoid Arthritis by Strand, Vibeke, Tundia, Namita, Song, Yan, Macaulay, Dendy, Fuldeore, Mahesh

“…Targeted immunomodulators (TIMs), including biologic disease-modifying antirheumatic drugs (DMARDs) and JAK/STAT inhibitors, are effective therapies for…”
Get full text

Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis by Guandalini, Stefano, Tundia, Namita, Thakkar, Roopal, Macaulay, Dendy, Essenmacher, Kirk, Fuldeore, Mahesh

“…Background Celiac disease (CeD) is an autoimmune disease triggered by gluten ingestion. Aim We assessed total direct costs burden associated with CeD in…”
Get full text

Healthcare utilization and costs among women diagnosed with uterine fibroids: a longitudinal evaluation for 5 years pre- and post-diagnosis by Fuldeore, Mahesh, Yang, Hongbo, Soliman, Ahmed M, Winkel, Craig

“…To evaluate the healthcare utilization, treatments, and costs incurred by women with uterine fibroids (UF), compared to those without UF, for 5 years before…”
Get full text

Poster: CLL-410 Adherence and Discontinuation Among Medicare Beneficiaries Initiating Venetoclax versus BTKis for Relapsed/Refractory Chronic Lymphocytic Leukemia by Huntington, Scott F, Manzoor, Beenish S, Puckett, Justin T, Kamal-Bahl, Sachin, Alhasani, Hasan, Ravelo, Arliene, Fuldeore, Mahesh, Doshi, Jalpa A

Get full text